Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded sponsor attribution clarification for Naurex, Inc., an affiliate of Allergan plc, and introduced new section headers such as More Information and Helpful Links Provided by. The page revision indicator was updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAncillary sponsor attribution and navigation link labels have been removed from the study record, reducing auxiliary information while preserving the primary study details.SummaryDifference0.1%

- Check30 days agoChange DetectedA new site revision is shown as Revision: v3.5.3, replacing the previous v3.5.2, indicating a software update underlying the page rendering.SummaryDifference0.0%

- Check37 days agoChange DetectedUpdated the page’s informational/footer elements (including the “More Information” area and helpful links) and refreshed the displayed site revision number from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check44 days agoChange DetectedThe sponsor line 'Naurex, Inc, an affiliate of Allergan plc' was removed. The sections 'More Information' and 'Helpful Links Provided by' were also removed.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.